C-SKNY

C:SKNY - LIR Life Sciences Corp. - https://lirlife.com/

02:20:26 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
SKNY - C	0.2	1.37	·	1.41	2.7	1.41	+0.03	2.2	66.9	89	78	1.37 1.43 1.35	2.41 0.30	15:59:49	Feb 05	15 min RT 2¢
CSE - C	0.2	1.37	·	1.41	2.7	1.37	-0.01	-0.7	48.0	65	39	1.37 1.40 1.37	2.41 0.30	15:59:47		15 min
NEO ATS - U						1.39	+0.01	0.7	2.3	3	6	1.40 1.40 1.39		15:25:13		15 min
Omega - O						1.41	+0.03	2.2	6.8	9	15	1.35 1.41 1.35		15:59:49		15 min
CX2 - H						1.37	-0.01	-0.7	3.7	5	6	1.40 1.41 1.37		15:59:47		15 min
CXD - D						1.43	+0.05	3.6	0.9	1	3	1.40 1.43 1.40		09:55:14		15 min
MatchNOW - M						1.38			5.2	7	9					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 78

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:49	O	1.41	0.03	100	14 Virtu ITG	1 Anonymous	K
15:59:47	O	1.37	-0.01	400	14 Virtu ITG	1 Anonymous	K
15:59:47	O	1.37	-0.01	200	14 Virtu ITG	1 Anonymous	K
15:59:47	H	1.37	-0.01	400	14 Virtu ITG	1 Anonymous	K
15:59:47	O	1.37	-0.01	600	14 Virtu ITG	1 Anonymous	K
15:59:47	C	1.37	-0.01	600	36 Latimer	1 Anonymous	K
15:59:47	M	1.38		1,000	1 Anonymous	1 Anonymous
15:59:33	H	1.41	0.03	100	14 Virtu ITG	1 Anonymous	K
15:59:18	O	1.41	0.03	100	14 Virtu ITG	1 Anonymous	K
15:59:01	O	1.41	0.03	100	14 Virtu ITG	1 Anonymous	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2026-02-05 18:00	C:SKNY	1.38	News Release200	LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
2026-01-30 04:03	C:SKNY	1.98	News Release200	LIR Life receives positive GLP/GIP therapy results
2026-01-22 18:00	C:SKNY	1.85	News Release200	LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
2026-01-16 03:41	C:SKNY	1.93	News Release200	LIR Life launches animal transdermal study
2026-01-08 18:00	C:SKNY	2.26	News Release200	LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
2025-12-29 16:31	C:SKNY	1.73	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-12-29 16:25	C:SKNY	1.73	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-12-18 18:00	C:SKNY	1.31	News Release200	LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
2025-12-11 21:38	C:SKNY	1.59	News Release200	LIR Life Sciences files provisional patent application
2025-12-10 20:40	C:SKNY	1.55	News Release200	LIR Life designs GLP/GIP-based obesity therapy study
2025-11-26 21:13	C:SKNY	0.65	News Release200	Lir Life Sciences hires MCS for on-line marketing
2025-11-10 23:07	C:SKNY	0.63	News Release200	LIR Life Sciences closes acquisition, names Mills CEO
2025-11-06 17:50	C:SKNY		New Listing5	Blackbird Critical name change to LIR Life, rollback
2025-11-06 17:50	C:BBRD	0.20	Change Name, Roll Back Shares290	Blackbird Critical name change to LIR Life, rollback
2025-11-06 12:10	C:BBRD	0.20	News Release200	CSE Bulletin: Fundamental Change - Blackbird Critical Metals Corp./LIR Life Sciences Corp.
2025-10-29 19:49	C:BBRD	0.20	News Release200	Blackbird receives conditional CSE approval for Lir buy
2025-10-07 17:41	C:BBRD	0.20	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-10-07 17:41	C:BBRD	0.20	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-10-07 15:33	C:BBRD	0.20	Cease Trade/Suspend Company180	Blackbird Critical Metals suspended by CSE
2025-10-07 10:34	C:BBRD	0.20	News Release200	CSE Bulletin: Suspensions - AFI, BBRD

Date ET

Symbol

Price

Type

Headline

2026-02-05 18:00

C:SKNY

1.38

News Release

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories

2026-01-30 04:03

C:SKNY